These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 26785407)

  • 1. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
    Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
    PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a newborn screening and follow-up programme for sickle cell disease among South Gujarat (India) tribal populations.
    Italia Y; Krishnamurti L; Mehta V; Raicha B; Italia K; Mehta P; Ghosh K; Colah R
    J Med Screen; 2015 Mar; 22(1):1-7. PubMed ID: 25341880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience.
    Pandey H; Singh K; Ranjan R; Pandey SK; Sharma A; Kishor K; Seth T; Mahapatra M; Saxena R
    Hematology; 2019 Dec; 24(1):349-352. PubMed ID: 30777489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle Cell Disease in Central India: A Potentially Severe Syndrome.
    Jain D; Warthe V; Dayama P; Sarate D; Colah R; Mehta P; Serjeant G
    Indian J Pediatr; 2016 Oct; 83(10):1071-6. PubMed ID: 27053181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell disease in India.
    Colah R; Mukherjee M; Ghosh K
    Curr Opin Hematol; 2014 May; 21(3):215-23. PubMed ID: 24714525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
    Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab--a single centre experience in eastern India.
    Patel S; Purohit P; Mashon RS; Dehury S; Meher S; Sahoo S; Dash SS; Das K; Das P; Patel DK
    Pediatr Blood Cancer; 2014 Aug; 61(8):1341-6. PubMed ID: 24616059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
    Mellouli F; Bejaoui M
    Arch Pediatr; 2008 Jan; 15(1):24-8. PubMed ID: 18164913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening shows a high incidence of sickle cell anemia in Central India.
    Jain DL; Sarathi V; Upadhye D; Gulhane R; Nadkarni AH; Ghosh K; Colah RB
    Hemoglobin; 2012; 36(4):316-22. PubMed ID: 22712682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
    Steinberg MH; Barton F; Castro O; Pegelow CH; Ballas SK; Kutlar A; Orringer E; Bellevue R; Olivieri N; Eckman J; Varma M; Ramirez G; Adler B; Smith W; Carlos T; Ataga K; DeCastro L; Bigelow C; Saunthararajah Y; Telfer M; Vichinsky E; Claster S; Shurin S; Bridges K; Waclawiw M; Bonds D; Terrin M
    JAMA; 2003 Apr; 289(13):1645-51. PubMed ID: 12672732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbSD-Punjab: clinical and hematological profile of a rare hemoglobinopathy.
    Oberoi S; Das R; Trehan A; Ahluwalia J; Bansal D; Malhotra P; Marwaha RK
    J Pediatr Hematol Oncol; 2014 Apr; 36(3):e140-4. PubMed ID: 24276032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn Screening and Clinical Profile of Children With Sickle Cell Disease in a Tribal Area of Gujarat.
    Dave K; Desai S; Italia Y; Mukherjee MB; Mehta P; Desai G
    Indian Pediatr; 2022 Mar; 59(3):230-233. PubMed ID: 35014619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
    Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
    Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.
    Keikhaei B; Yousefi H; Bahadoram M
    Glob J Health Sci; 2015 Aug; 8(3):252-6. PubMed ID: 26493428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
    Rigano P; De Franceschi L; Sainati L; Piga A; Piel FB; Cappellini MD; Fidone C; Masera N; Palazzi G; Gianesin B; Forni GL;
    Blood Cells Mol Dis; 2018 Mar; 69():82-89. PubMed ID: 29107441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
    Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia.
    Opoka RO; Ndugwa CM; Latham TS; Lane A; Hume HA; Kasirye P; Hodges JS; Ware RE; John CC
    Blood; 2017 Dec; 130(24):2585-2593. PubMed ID: 29051184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.